- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 11 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.12: 1 residues within 4Å:- Chain A: N.165
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: N.282
- Chain C: K.558
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: T.307, N.603
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: H.655, N.657
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain A: N.709, I.1130, G.1131
- Chain B: D.796
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: I.1132, N.1134
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.616, T.618
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain B: N.122, F.157
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain B: E.132, N.165
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain B: N.280, N.282, T.284
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain B: N.343
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: H.655, N.657
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain B: N.709, I.1130, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain B: N.717, Q.926, Q.1071
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: N.1098, T.1100, F.1103
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: I.1132, N.1134
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.616, T.618
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: N.280, N.282, T.284
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain C: F.338, F.342, N.343, L.368
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain C: N.603, T.604
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain C: N.616
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain C: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.1098
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain C: N.1134
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Scheid, J.F. et al., B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV. Cell (2021)
- Release Date
- 2021-05-05
- Peptides
- Spike glycoprotein: ABC
BG7-15 Fab Heavy Chain: DE
BG7-15 Fab Light Chain: FG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
RF
LG
S
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 11 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Scheid, J.F. et al., B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV. Cell (2021)
- Release Date
- 2021-05-05
- Peptides
- Spike glycoprotein: ABC
BG7-15 Fab Heavy Chain: DE
BG7-15 Fab Light Chain: FG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
RF
LG
S